Media headlines about DS Healthcare Group (NASDAQ:DSKX) have trended positive this week, Accern reports. Accern rates the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. DS Healthcare Group earned a news impact score of 0.40 on Accern’s scale. Accern also assigned news articles about the specialty retailer an impact score of 45.2988660068385 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Shares of DS Healthcare Group (DSKX) remained flat at $0.01 during trading on Wednesday. DS Healthcare Group has a 52-week low of $0.01 and a 52-week high of $0.67. The firm has a 50-day moving average price of $0.03 and a 200-day moving average price of $0.09.

In other DS Healthcare Group news, CEO Yasuhiro Fujiwara purchased 2,500,000 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The stock was purchased at an average cost of $0.10 per share, with a total value of $250,000.00. Following the acquisition, the chief executive officer now directly owns 2,815,000 shares of the company’s stock, valued at approximately $281,500. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. 19.40% of the stock is owned by corporate insiders.

WARNING: This news story was published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.watchlistnews.com/ds-healthcare-group-dskx-earning-positive-media-coverage-accern-reports/1607644.html.

About DS Healthcare Group

DS Healthcare Group, Inc, doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs.

Insider Buying and Selling by Quarter for DS Healthcare Group (NASDAQ:DSKX)

Receive News & Ratings for DS Healthcare Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.